Megan Adediran: Giving Hope to People Living with Bleeding Disorders
Megan Adediran, Executive Director at Hemophilia Foundation of Nigeria, shared a post LinkedIn:
“My journey in advocacy began through the pain of watching my son live with a bleeding disorder and experiencing firsthand the fear, uncertainty, and challenges that come with limited awareness and access to care.
As I walked that journey with him, I began to see that many other individuals and families were also suffering silently due to delayed diagnosis, stigma, misunderstanding, and inadequate support.
Over the years, I have listened to stories of pain, resilience, and survival that strengthened my passion to keep speaking up for those whose voices are often unheard, especially women and girls whose symptoms are frequently dismissed or misunderstood.
Through awareness campaigns, community engagements, partnerships, and storytelling, I have learned that advocacy is not just about raising awareness.
It is about creating change, restoring hope, and ensuring that people feel seen, heard, and supported.
This journey continues to remind me that one voice, when used with purpose, can truly make a difference.”
Other posts featuring Megan Adediran on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients